Facilitators and barriers to medication adherence among stroke survivors in India

被引:11
作者
Shani, S. D. [1 ]
Sylaja, P. N. [2 ]
Sarma, P. Sankara [1 ]
Kutty, V. Raman [3 ]
机构
[1] Sree Chitra Tirunal Inst Med Sci & Technol SCTIMS, Achutha Menon Ctr Hlth Sci Studies AMCHSS, Thiruvananthapuram, Kerala, India
[2] Sree Chitra Tirunal Inst Med Sci & Technol SCTIMS, Dept Neurol, Thiruvananthapuram 695011, Kerala, India
[3] Amala Canc Res Ctr, Trichur 680555, India
关键词
Medication adherence; Risk factor control; Stroke survivors; Life style; India; SECONDARY PREVENTION; ISCHEMIC-STROKE; RISK;
D O I
10.1016/j.jocn.2021.03.019
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Strict compliance with medication and life style modification are integral to secondary stroke prevention. This study was undertaken to find out medication adherence among stroke survivors and factors associated with it. Cross sectional survey among stroke survivors was conducted. Interview based self-reported medication adherence was defined as consumption at least >80% of their medications for last two weeks, based on last prescription. Structured interview using pretested interview schedule was done to collect other data. Sequential step wise logistic regression analysis was done to find out the facilitators and barriers to medication adherence. Two hundred and forty stroke survivors (mean age 58.64 +/- 10.96 years; 25.4% females) with a mean post-stroke period of 6.65 +/- 3.36 months were participated. Overall medication adherence was 43.8% (n = 105). Medication adherence was 34.3% (n = 134), 52.6% (n = 190) and 56.7% (n = 224) for antidiabetics, antihypertensives and statins respectively and was associated with risk factor control (Diabetes: Odds Ratio (OR) = 4.85; 95% Confidence Interval (CI) 2.12-11.08, Hypertension: OR = 3.42; 95% CI 1.83-6.4, Dyslipidaemia: OR = 3.88; 95% CI 1.96-4.04). Having daily routine (OR = 2.82; 95% CI 1.52-5.25), perceived need of medication (OR = 2.33; 95% CI 1.04-5.2) and perceived poor state of health (OR = 2.65; 95% CI 1.30-5.40) were facilitators. Memory issues (OR = 0.34; 95% CI 0.16-0.71), side effects (OR = 0.24; 95% CI 0.11-0.42) and financial constraints (OR = 0.46; 95% CI 0.24-0.91) were barriers to medication adherence. Establishing daily routines, periodic reminders, financial supports to buy medicines and patient education can enhance medication adherence to prevent future strokes. (c) 2021 Elsevier Ltd. All rights reserved.
引用
收藏
页码:185 / 190
页数:6
相关论文
共 50 条
  • [21] Patient Perspectives on Short-Course Pharmacotherapy: Barriers and Facilitators to Medication Adherence
    Sherwin, LeeAnne B.
    Ross, Diana
    Matteson-Kome, Michelle
    Bechtold, Matthew
    Deroche, Chelsea
    Wakefield, Bonnie
    JOURNAL OF PATIENT EXPERIENCE, 2020, 7 (05): : 726 - 733
  • [22] Medication adherence after pediatric allogeneic stem cell transplantation: Barriers and facilitators
    Hoegy, Delphine
    Bleyzac, Nathalie
    Rochet, Chrystele
    De Freminville, Humbert
    Renard, Cecile
    Kebaili, Kamila
    Bertrand, Yves
    Dussart, Claude
    Janoly-Dumenil, Audrey
    EUROPEAN JOURNAL OF ONCOLOGY NURSING, 2019, 38 : 1 - 7
  • [23] Facilitators and barriers to antiretroviral therapy adherence among adolescents in Ghana
    Ankrah, Daniel N. A.
    Koster, Ellen S.
    Mantel-Teeuwisse, Aukje K.
    Arhinful, Daniel K.
    Agyepong, Irene A.
    Lartey, Margaret
    PATIENT PREFERENCE AND ADHERENCE, 2016, 10 : 329 - 337
  • [24] Key Barriers to Medication Adherence in Survivors of Strokes and Transient Ischemic Attacks
    Kronish, Ian M.
    Diefenbach, Michael A.
    Edmondson, Donald E.
    Phillips, L. Alison
    Fei, Kezhen
    Horowitz, Carol R.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2013, 28 (05) : 675 - 682
  • [25] Key Barriers to Medication Adherence in Survivors of Strokes and Transient Ischemic Attacks
    Ian M. Kronish
    Michael A. Diefenbach
    Donald E. Edmondson
    L. Alison Phillips
    Kezhen Fei
    Carol R. Horowitz
    Journal of General Internal Medicine, 2013, 28 : 675 - 682
  • [26] Adherence to highly active antiretroviral therapy in Hyderabad, India: barriers, facilitators and identification of target groups
    Dworkin, Mark S.
    Douglas, G. W.
    Rani, G. P. Sabitha
    Chakraborty, Apurba
    INTERNATIONAL JOURNAL OF STD & AIDS, 2016, 27 (03) : 186 - 195
  • [27] Factors Influencing 1-Year Medication Adherence of Korean Ischemic Stroke Survivors
    Gye-Gyoung Kim
    Duck-Hee Chae
    Man-Seok Park
    Sung-Hee Yoo
    International Journal of Behavioral Medicine, 2020, 27 : 225 - 234
  • [28] A Systematic Review of Randomized Controlled Trials of Medication Adherence Interventions in Adult Stroke Survivors
    Wessol, Jennifer L.
    Russell, Cynthia L.
    Cheng, An-Lin
    JOURNAL OF NEUROSCIENCE NURSING, 2017, 49 (02) : 120 - 133
  • [29] Do facilitators and barriers to community ambulation differ among stroke survivors in low resource settings? A cross-sectional study in Nigeria
    Odetunde, Marufat O.
    Olaoye, Olumide A.
    Ogwogho, Halimat O.
    Onigbinde, Ayodele Teslim
    TOPICS IN STROKE REHABILITATION, 2024, : 349 - 361
  • [30] A Qualitative Study of Barriers and Facilitators to Adherence to Secondary Prevention Medications Among French Patients Suffering from Stroke and Transient Ischemic Attack
    Viprey, Marie
    Gouillet, Mailys
    Puppo, Costanza
    Termoz, Anne
    Della Vecchia, Claire
    Derex, Laurent
    Haesebaert, Julie
    Schott, Anne-Marie
    Preau, Marie
    PATIENT PREFERENCE AND ADHERENCE, 2020, 14 : 1213 - 1223